To clarify that apparent paradox, we have designed a comprehensive methodological approach in which both IHC and quantitative gene expression were used to investigate RANK in primary endometrial tumors from which clinicopathological features were available. This evidence concerns the gene TNFRSF11A and endometrium neoplasm.